← Open Payments lookup

CAROLINE BLOSS: Open Payments

NPI 1003582008 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$747 in 34 payments from 13 companies in 2025. Trend: 2023 $1,797 · 2024 $1,814 · 2025 $747

Food & beverage: $747
CompanyPaymentsAmount
ABBVIE INC.7$162
GlaxoSmithKline, LLC.4$103
AstraZeneca Pharmaceuticals LP5$90
Lilly USA, LLC3$78
SHIELD THERAPEUTICS INC1$54
Astellas Pharma US Inc2$47
PFIZER INC.2$44
Novo Nordisk Inc2$40
Kowa Pharmaceuticals America, Inc.2$35
Phathom Pharmaceuticals, Inc.2$29

Products named: VRAYLAR, TRELEGY ELLIPTA, ACCRUFER, MOUNJARO, Veozah, FARXIGA, ZORYVE, VOQUEZNA.

Industry payments across PA — which companies pay providers there.